Patent Assignment
Reel/Frame 066026/0610
Security Interest
Recorded: 2024-01-04
Pages: 10
Assignor
AVENCELL THERAPEUTICS, INC.
Executed: 2024-01-04
Assignee
BXLS V - DIAMANT L.P., AS COLLATERAL AGENT
314 MAIN STREET, FLOOR 15, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(13)
A Targeting Module Comprising Pd-L1 and/or Pd-L2 for Use in a Method for Stimulating a Chimeric Antigen Receptor Mediated Immune Response in a Mammal
Application:
17/911,678 →
Publication:
US 2023/0183351
Reversed Universal Chimeric Antigen Receptor Expressing Immune Cells for Targeting of Diverse Multiple Antigens and Method of Manufacturing the Same and Use of the Same for Treatment of Cancer, Infections and Autoimmune Disorders
Application:
17/251,447 →
Publication:
US 2021/0309751
Universal Chimeric Antigen Expressing Immune Cells for Targeting of Diverse Multiple Antigens and Method of Manufacturing the Same and Use of the Same for Treatment of Cancer, Infections and Autoimmune Disorders
Universal Chimeric Antigen Expressing Immune Cells for Targeting of Diverse Multiple Antigens and Method of Manufacturing the Same and Use of the Same for Treatment of Cancer, Infections and Autoimmune Disorders
Universal Chimeric Antigen Expressing Immune Cells for Targeting of Diverse Multiple Antigens and Method of Manufacturing the Same and Use of the Same for Treatment of Cancer, Infections and Autoimmune Disorders
Application:
16/798,255 →
Publication:
US 2021/0206828
Targeting Modules for Universal Chimeric Antigen Receptor Expressing Immune Cells and Use in the Treatment of Cancer Infections and Autoimmune Disorders
Targeting Modules for Universal Chimeric Antigen Receptor Expressing Immune Cells and Use in the Treatment of Cancer, Infections and Autoimmune Disorders
Human Mesenchymal Stem Cells and Uses Thereof
Application:
62/088,578 →
Anti-La Antibodies and Their Use for Immunotargeting
Anti-La Antibodies and Their Use for Immunotargeting
Antibodies against prostate-specific stem cell antigen and use thereof
Anti-CD33 Antibodies and Use Thereof for Immunotargeting in Treating CD33-Associated Illnesses
Targeting Modules Against CD123 for Use in a Method for Stimulating a Chimeric Antigen Receptor-Mediated Immune Response in a Mammal
PCT:
PCT/US2023/068998 ↗
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 2, 2012
From: BACHMANN, MICHAEL; STAMOVA, SLAVA
To: TECHNISCHE UNIVERSITAET DRESDEN
Reel/Frame 028307/0601 →
Assignment of Assignor's Interest
May 3, 2013
From: BACHMANN, MICHAEL
To: TECHNISCHE UNIVERSITAET DRESDEN
Reel/Frame 030341/0576 →
Assignment of Assignor's Interest
Dec 28, 2013
From: BACHMANN, MICHAEL
To: TECHNISCHE UNIVERSITAET DRESDEN
Reel/Frame 031855/0862 →
Assignment of Assignor's Interest
Mar 12, 2014
From: TECHNISCHE UNIVERSITAET DRESDEN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 032411/0131 →
Change of Address
Oct 29, 2014
From: TECHNISCHE UNIVERSITAET DRESDEN
To: TECHNISCHE UNIVERSITAET DRESDEN
Reel/Frame 034087/0041 →
Assignment of Assignor's Interest
Dec 3, 2014
From: TECHNISCHE UNIVERSITAET DRESDEN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 034352/0546 →
Assignment of Assignor's Interest
Mar 16, 2015
From: EHNINGER, ARMIN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 035170/0744 →
Assignment of Assignor's Interest
Nov 23, 2016
From: TECHNISCHE UNIVERSITAET DRESDEN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 040413/0721 →
Assignment of Assignor's Interest
Nov 23, 2016
From: BACHMANN, MICHAEL
To: TECHNISCHE UNIVERSITAET DRESDEN
Reel/Frame 040413/0640 →
Change of Address
Nov 23, 2016
From: TECHNISCHE UNIVERSITAET DRESDEN
To: TECHNISCHE UNIVERSITAET DRESDEN
Reel/Frame 040680/0839 →
Assignment of Assignor's Interest
Sep 15, 2017
From: BACHMANN, MICHAEL; EHNINGER, ARMIN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 043602/0138 →
Assignment of Assignor's Interest
Dec 3, 2019
From: EHNINGER, ARMIN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 051163/0010 →
Assignment of Assignor's Interest
Feb 18, 2020
From: BACHMANN, MICHAEL; EHNINGER, ARMIN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 051851/0079 →
Assignment of Assignor's Interest
Apr 19, 2020
From: BACHMANN, MICHAEL; EHNINGER, ARMIN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 052436/0024 →
Assignment of Assignor's Interest
Dec 11, 2020
From: BACHMANN, MICHAEL
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 054617/0820 →
Change of Name
Nov 23, 2021
From: GEMOAB MONOCLONALS GMBH
To: GEMOAB GMBH
Reel/Frame 058566/0170 →
Change of Name
Mar 17, 2022
From: GEMOAB GMBH
To: AVENCELL EUROPE GMBH
Reel/Frame 059390/0606 →
Change of Name
May 26, 2022
From: GEMOAB GMBH
To: AVENCELL EUROPE GMBH
Reel/Frame 060202/0628 →
Assignment of Assignor's Interest
Apr 11, 2023
From: EHNINGER, ARMIN
To: AVENCELL EUROPE GMBH
Reel/Frame 063289/0311 →
Assignment of Assignor's Interest
Sep 7, 2023
From: SPEHR, JOHANNES; EHNINGER, ARMIN
To: AVENCELL THERAPEUTICS INC.
Reel/Frame 064832/0701 →
Change of Name
Oct 7, 2024
From: GEMOAB GMBH
To: AVENCELL EUROPE GMBH
Reel/Frame 069114/0705 →
Change of Name
Oct 7, 2024
From: GEMOAB MONOCLONALS GMBH
To: GEMOAB GMBH
Reel/Frame 069826/0516 →
Assignment of Assignor's Interest
Oct 7, 2024
From: EHNINGER, ARMIN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 068814/0770 →
Release of Security Interest
Oct 18, 2024
From: BXLS V – DIAMANT L.P.
To: AVENCELL THERAPEUTICS, INC.
Reel/Frame 068941/0187 →